We are live on ! Find out more
LCP

Legacy Capital Partners Portfolio holdings

AUM $304M
1-Year Est. Return 20.42%
This Fund
S&P 500
This Quarter Est. Return
+9.12%
1 Year Est. Return
+20.42%
3 Year Est. Return
+85.6%
5 Year Est. Return
+136.75%
10 Year Est. Return
AUM
$248M
AUM Growth
+$19.7M
Cap. Flow
+$1.59M
Cap. Flow %
0.64%
Top 10 Hldgs %
28.25%
Holding
161
New
13
Increased
67
Reduced
47
Closed
4

Sector Composition

Rank Sector Weight
1 Technology 25.38%
2 Healthcare 14.56%
3 Financials 12.67%
4 Consumer Staples 10.97%
5 Consumer Discretionary 7.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZTS icon
151
Zoetis
ZTS
$32.3B
$212K 0.09%
1,600
-825
-34% -$103K
TMO icon
152
Thermo Fisher Scientific
TMO
$213B
$211K 0.09%
+650
New +$197K
DGX icon
153
Quest Diagnostics
DGX
$25.6B
$208K 0.08%
1,950
TEL icon
154
TE Connectivity
TEL
$59.4B
$201K 0.08%
+2,094
New +$194K
NG icon
155
NovaGold Resources
NG
$2.6B
$200K 0.08%
22,300
CHS
156
DELISTED
Chicos FAS, Inc.
CHS
$38K 0.02%
10,000
VGZ icon
157
Vista Gold
VGZ
$260M
$16K 0.01%
21,500
BIDU icon
158
Baidu
BIDU
$38.3B
-2,835
Closed -$291K
SCHO icon
159
Schwab Short-Term US Treasury ETF
SCHO
$12.8B
-10,776
Closed -$273K
SCHR
160
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
-15,006
Closed -$417K
CELG
161
DELISTED
Celgene Corp
CELG
-16,192
Closed -$1.61M

Similar funds

Legacy Capital Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Legacy Capital Partners held 161 positions worth $248M, up 8.6% from $228M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Legacy Capital Partners's Q4 2019 filing shows 13 new, 67 increased, 47 reduced and 4 closed positions. Its largest new stake was Adobe: 1,370 shares worth $452K. The largest sale was Celgene Corp, an estimated $1.61M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

  • Legacy Capital Partners's largest Q4 2019 buy was Adobe: 1,370 shares worth $452K.
  • Legacy Capital Partners added most to Bristol-Myers Squibb in Q4 2019, an estimated $892K increase.
  • Legacy Capital Partners's biggest Q4 2019 reduction was Apple, cutting an estimated $1.18M.
  • Legacy Capital Partners fully exited Celgene Corp in Q4 2019, selling an estimated $1.61M.
  • Legacy Capital Partners's ten largest holdings make up 28% of its $248M portfolio in Q4 2019.
  • Legacy Capital Partners opened 13 new positions and closed 4 in Q4 2019.
  • Legacy Capital Partners's portfolio value rose 8.6% quarter-over-quarter to $248M.

Based on Legacy Capital Partners's 13F filing for Q4 2019, filed 14 Jan 2020.